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PURPOSE. To unravel the relationship between African ancestry, central corneal thickness
(CCT), and intraocular pressure (IOP) by estimating the genetic African ancestry (GAA)
proportion in primary open-angle glaucoma (POAG) patients and controls from an admixed
South African Colored (SAC) and a South African Black (SAB) population.
METHODS. In this case-control study, 268 POAG patients and 137 controls were recruited from
a university clinic in Cape Town, South Africa. All participants were genotyped on the
Illumina HumanOmniExpress beadchip or HumanOmni2.5Exome beadchip. ADMIXTURE
was used to infer participant’s GAA among 86,632 SNPs. Linear and logistic regression models
were used to assess the relation between GAA, POAG, CCT, and IOP.
RESULTS. The median proportion of GAA was 60% in the study population. GAA was
significantly associated with thinner CCT (P < 0.001) and IOP (P ¼ 0.034) in POAG patients.
The effect of GAA on CCT was marginally different among POAG patients versus controls (P
¼ 0.066). In POAG patients, the CCT was significantly thinner compared to controls after
adjusting for age and sex (P ¼ 0.016). In a stratified analysis in participants with >60% GAA,
CCT was not associated with POAG (P ¼ 0.550).
CONCLUSIONS. This study demonstrated that a higher proportion of GAA was associated with a
thinner CCT and a higher IOP in POAG patients. Remarkably, at higher proportions of GAA,
the difference in CCT between POAG and controls was reduced. This suggests that thinner
CCT is not associated with POAG in Africans.
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Primary open-angle glaucoma (POAG) is the predominanttype of glaucoma worldwide and a leading cause of
irreversible blindness.1,2 In African populations, the prevalence
is approximately three times higher compared to European
populations and it runs a more severe course with higher
intraocular pressure (IOP).3–9 The IOP is a major risk factor for
POAG and the only one that can be modified therapeutically to
alter the progression rate of the disease. Therefore, it is
essential that it is measured accurately. The reliability of IOP
measurements, especially Goldmann applanation tonometry
(GAT), is confounded by variations in central corneal thickness
(CCT), which affects the rigidity of the cornea.10 Not only does
CCT affect the accuracy of GAT, but CCT also is reported to be a
strong predictor of the development of POAG in ocular
hypertensive patients, even when IOP is corrected for CCT.11
Moreover, in the Early Manifest Glaucoma Trial, CCT was
reported to be an independent predictive factor for longer-term
progression of POAG in patients with higher baseline IOP.12
Nevertheless, whether the effect of CCT on glaucoma is
only due to its effects on IOP measurement error or
whether an independent relationship between CCT and
glaucoma truly exists remains controversial.11–15 Large
population-based studies could not find any association of
CCT with POAG. Other studies suggest that CCT is
correlated with scleral and lamina cribrosa thickness, which
affects the properties and vulnerability of the optic nerve
and, therefore, increases the risk of glaucoma. However,
histomorphometric studies in humans and monkeys could
not confirm this correlation.16,17 Other biomechanical
characteristics have been suggested to link CCT with POAG,
such as the viscoelasticity of the cornea or corneal
hysteresis. Lower corneal hysteresis has been associated
with an increased risk of glaucoma and glaucoma progres-
sion.18–22
CCT follows a diurnal rhythm and is affected by sex,
age, and ethnicity.23–27 The ethnic variation of CCT has
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been studied widely. A meta-analysis including 53 studies
showed that African individuals have a 20 to 30 lm thinner
CCT compared to Europeans, Hispanics, and East Asians.28
However, the possible relationship between a thinner CCT
in individuals of African ancestry and their observed
increased POAG risk has not been addressed sufficiently.
The purpose of this study was to disentangle the
relationships between African ancestry, CCT, and IOP in POAG
patients and controls. To overcome inaccuracy due to
reporting bias and to study the effect of African ancestry
quantitatively, we assessed each participant’s biogeographic
ancestry by inferring the genetic African Ancestry (GAA) rather
than the self-reported ancestry.
METHODS
Study Population
The Genetics in Glaucoma patients of African descent
study (GIGA study) is a case-control study comprising
open-angle glaucoma patients and healthy controls from
South Africa. All participants (n ¼ 405) provided a written
informed consent in accordance with the ethical standards
as stated in the Declaration of Helsinki. The institutional
review boards of the Erasmus MC and the University of
Cape Town granted ethical approval. Participants were
ascertained at the ophthalmology outpatient department of
the Groote Schuur Hospital in Cape Town, South Africa. In
total, 268 POAG patients met the inclusion criteria of the
study. Inclusion criteria were participants of South African
Black (SAB) or admixed South African Colored (SAC)29
descent, over 35 years of age, and diagnosed with either
POAG or normal tension glaucoma (NTG). All other types
of glaucoma, including secondary causes or narrow/closed
angle glaucoma, were excluded. Inclusion criteria for
controls (n ¼ 137) were persons aged over 55 years, of
SAB or SAC descent, without a diagnosis of any form of
glaucoma, and without a family history (first degree
relatives) of glaucoma. All participants were examined by
a local glaucoma specialist.
Ophthalmic Examination
The complete eye examination included visual acuity (VA) by
using a Snellen or Tumbling E chart at 6 m with and without
correction, refraction, IOP measurement with GAT, slit-lamp
examination including peripheral anterior chamber depth
assessment by the Van Herick method, indirect gonioscopy,
funduscopy for optic nerve head examination, and digital
fundus photography centered on the optic nerve by means of a
Canon CF-60DSi fundus camera.
CCT was measured after topical instillation of lidocaine
anesthetics with an ultrasonic A-scan/pachymeter OcuScan
RxP (Alcon Laboratories, Inc., Ft. Worth, TX, USA). Ten
readings were automatically captured in both eyes.
Visual field testing was performed with the Humphrey
Field Analyzer 24-2 Sita Fast (Carl Zeiss Meditec, Inc.,
Dublin, CA, USA) strategy. A definite visual field defect
consistent with glaucoma was defined if the glaucoma
hemifield test graded ‘‘outside normal limits’’ and if a
cluster of 3 contiguous points was observed at the 5% level
of the pattern deviation plot, including at least 1 of these
points <1%. Field defects were not attributed to glaucoma
in the presence of media opacities or nonglaucomatous
optic nerve disease that could explain the visual field
abnormality.
Inclusion Criteria
All patients were categorized as glaucomatous according to
the ISGEO classification for open-angle glaucoma.30 After
preliminary screening by local glaucoma specialists, and
grading of fundus photographs by one senior ophthalmolo-
gist and one trained research grader, detailed grading was
performed independently by one general ophthalmologist
(AAT) and one glaucoma specialist (HGL). They interpreted
fundus images and visual field results independently while
being masked for other clinical information. In case of any
discrepancy between the two graders, adjudication was
solved by consensus. If no consensus was reached,
participants were excluded. Category 1 or 2 ISGEO criteria
had to be met to diagnose glaucoma. The highest level of
evidence (category 1) requires a definite visual field defect,
as mentioned above, and loss of the neuroretinal rim with a
Vertical Cup Disc Ratio (VCDR) ‡ 0.7, or VCDR asymmetry
‡ 0.2 (both values represented the ‡97.5th percentile for
the normal SAB population31). Visual field testing results
with less than 8% false-positive and false-negative responses,
and less than 10% fixation losses were considered reliable.
Category 2 requires a severely damaged optic disc, that is, a
VCDR > 0.8 or VCDR asymmetry > 0.2 (both values
determined by ‡99.5th percentile for the normal SAB
population31) in the absence of a satisfactory visual field
test.
In addition, patients with POAG demonstrated an open
angle on gonioscopy. Nonglaucomatous participants were
those who met the following criteria in both eyes: IOP  21
mm Hg, a nonglaucomatous optic disc with VCDR < 0.5, and
an intereye variation in VCDR <0.2.
Estimation of Genetic Ancestry
Participants were genotyped on the Illumina HumanOm-
niExpressExome beadchip (n ¼ 137) and the Illumina
HumanOmni2.5Exome beadchip (n ¼ 244). Before combin-
ing both genotype datasets, PLINK(v1.07) was used to
perform extensive quality control checks.32 No within
sample cryptic relatedness was observed during QC. To
make inferences based on populations of known ancestry,
we merged the combined dataset with 3 reference popula-
tions from Africa (Yoruba in Ibadan, Nigeria, and Luhya in
Webuye, Kenya), East-Asia (Japanese in Tokyo, Japan,
Southern Han Chinese, and Han Chinese in Beijing, China)
and Europe (Utah Residents [CEPH] with Northern and
Western Ancestry, Tuscany in Italy, Finnish in Finland, British
in England and Scotland, and Iberian in Spain) appearing in
the 1000 Genomes Project.33 PLINK then was used to
perform linkage disequilibrium pruning on the merged
genotype data to produce a reduced set of unlinked single
nucleoside polymorphism (SNPs) (–indep-pairwise 50 10
0.1); 86,632 autosomal SNPs with an SNP call rate of 100%
were selected from the merged datasets to estimate
biogeographic ancestry (BGA). First we examined the
genetic clustering by visualizing the principal components
calculated in PLINK (Supplementary Fig. S1). The program
ADMIXTURE v1.23 then was used to estimate the ancestral
fractions of the three putative ancestral populations—
African, Asian, and European—among the study samples.34
ADMIXTURE was run with default settings and K ¼ 3
ancestral populations.
Statistical Analysis
Since the mean CCTs of right and left eyes were not statistically
different (mean difference, 1.1 lm; P ¼ 0.242; Pearson
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correlation¼ 0.90), we only present the results of the right eye
analyses. If measurements from the right eye were not
available, then data from the left eye were used instead. In
total, 383 right eyes and 22 left eyes were available for analysis.
The average of the first 5 CCT readings was used in the
analysis. The independent samples Student’s t-test was used to
compare continuous variables among ethnic and diagnostic
groups. We performed v2 tests on categorical variables. GAA
fractions inferred from SNP data were used instead of self-
reported ethnicity to determine any association with African
ancestry. We studied four interrelationships among POAG,
GAA, CCT, and IOP as depicted in Figure 1. Univariable and
multivariable linear regression models, adjusting for age and
sex, were applied to test the association between GAA and
CCT, GAA and IOP, and CCT and IOP. Univariable and
multivariable logistic regression models, adjusting for age and
sex, were used to test the association of CCT with POAG. Also,
effect modification of CCT by GAA was tested in the
association of CCT with POAG by adding the multiplicative
interaction term to the adjusted model. All statistical analyses
were performed in SPSS (version 21.0; IBM Corp. Armonk. NY,
USA) and R studio (R Core Team [2014]; R Foundation for
Statistical Computing, Vienna, Austria).
RESULTS
Demographics and Clinical Characteristics
The demographic and clinical characteristics of the 268 POAG
patients and 137 controls are given in Table 1. In the control
group, there were significantly more women, and controls had
undergone more ocular surgery (in particular cataract extrac-
tion) compared to the POAG patients. In the POAG patients,
the untreated IOP was statistically significantly higher (P <
0.001) and the CCT was statistically significantly thinner than
in control participants (P ¼ 0.019). There was no statistically
significant difference in mean CCT among participants with
and without ocular surgery when adjusted for age, sex, and
POAG status (surgery, 507.1 6 40.5 lm, n ¼ 194; no surgery,
504.5 6 36.0, n ¼ 211; P ¼ 0.460). The CCT did not
significantly vary with age (0.23 lm per year; 95% confidence
interval [CI], 0.57–0.11; P ¼ 0.188). All CCT measurements
had been performed during daytime (9 AM to 5 PM), and there
was no association between CCT and the time of examination.
The distribution of self-reported ethnicity/race was similar for
POAG patients and controls. This was confirmed by an equal
median percentage GAA (Mann-Whitney U Test, P¼ 0.750) for
381 participants that were genotyped successfully. Figure 2
and Supplementary Table S1 present the distribution of the
percentage genetic Asian, African, and European ancestry
across SAB and SAC. The median proportion of GAA was
significantly different in SAC participants compared to SAB
participants (Mann-Whitney U Test, P < 0.001). One individual
FIGURE 1. Directed acyclic graph (DAG) depicting the interrelation-
ships among GAA, CCT, IOP, and POAG. Black arrow represent the
relationship between the primary independent variables (i.e., risk
factors) and the outcome (i.e., POAG). Gray arrows represent the
relationships between the independent variables (i.e., risk factors).
Dashed arrows represent relationships that were not further studied
because of the study design.
TABLE 1. Demographic and Clinical Characteristics
Demographic and Clinical Characteristics POAG, n ¼ 268 Controls, n ¼ 137 P Value*
Median age, y (IQR) 68.0 (20) 66.0 (12) 0.828
Female, n (%) 144 (53.7) 91 (66.4) 0.019
Ocular surgery, n (%) 110 (41.0) 84 (61.3) <0.001
IOP (untreated), mm Hg 6 SD 28.61 6 9.73 14.20 6 2.89 <0.001
CCT, lm 6 SD 502.53 6 37.00 511.92 6 39.82 0.019
Median VCDR (IQR) 0.90 (0.15) 0.30 (0.20) <0.001
Median proportion GAA, % (IQR) 61.24 (71.94) 55.37 (67.66) 0.750
IQR, interquartile range.
* P value obtained from a Student’s t-test for continuous variables and with v2 test for categorical variables. For median age and median VCDR
and median proportion GAA, P values were obtained with the Mann-Whitney U test.
FIGURE 2. Distribution of African (green), European (orange), and
Asian (blue) genetic ancestry per individual. Every individual is
represented by a vertical bar which is composed of three colors
corresponding to their proportion genetic ancestry from these
ancestral populations. The x-axis denotes individuals of self-reported
SAB descent and SAC descent. The y-axis denotes individual
proportions of genetic ancestry.
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of self-reported SAB descent had less than 25% GAA according
to the ADMIXTURE results, while 17 self-reported SAC
individuals (7%) had more than 80% GAA; three self-reported
SAC individuals (1.2%) did not have any GAA.
The results of the single exploratory analysis of the
interrelationships between GAA, IOP, CCT and POAG, as
graphically depicted in Figure 1, are presented in Table 2.
1. Relationship of CCT and GAA
For the relationship between CCT and GAA, we found a
statistically significant, negative association in the univariable
and multivariable regression model for controls and POAG
patients together (Punivariable < 0.001, Pmultivariable < 0.001).
For every 10% increase in GAA, CCT showed a mean decrease
of 4.4 lm (95% CI,5.4 to3.1). The regression lines for CCT
as a function of GAA in POAG patients and controls separately
are illustrated in Figure 3. For every 10% increment in GAA, the
CCT in the controls decreased by 5.4 lm, on average. In the
POAG patients, a 10% increase in GAA was associated with a
3.7 lm decrease in CCT. As an effect of the differences in the
slope for controls and POAG patients, the difference in CCT
between controls and POAG cases narrowed as the regression
lines converged.
2. Relationship of IOP and GAA
In the POAG patients, GAA was significantly associated with
IOP (P < 0.029), as shown in the multivariable regression
model. As such, for every 10% increase in GAA in POAG
patients IOP increased by 0.46 mm Hg. In controls, GAA was
not associated with IOP (P ¼ 0.131).
3. Relationship of IOP and CCT
We examined the association between CCT and IOP for POAG
patients and controls separately. In none of the groups there
was a statistically significant relationship between CCT and IOP
in a multivariable regression model adjusting for sex and age
(PPOAG ¼ 0.767; Pcontrol ¼ 0.204).
4. Relationship of POAG and CCT
Logistic regression analysis showed that a thinner CCT was
associated with an increased likelihood of POAG (Punivariable <
0.02, Pmultivariable < 0.019). A 10 lm decrease in CCT was
associated with approximately 7% higher odds of POAG after
adjusting for sex (P ¼ 0.017; odds ratio [OR], 0.59; 95% CI,
0.38–0.91), and age (age per year, P¼ 0.694; OR, 1.0; 95% CI,
0.97–1.02). To test if the relationship between CCT and POAG
was modified by GAA, we tested for effect modification by
adding the multiplicative interaction term between GAA and
CCT to the multivariable regression model. In addition, a
stratified analysis for median GAA (i.e., below and above the
median GAA value of 59.6%) was performed. No statistically
significant interaction between GAA and CCT was observed (P-
interaction¼ 0.112). When the data were stratified by median
GAA, the CCT was associated only with POAG for individuals
with a GAA less than 59.6% (P ¼ 0.044; Table 3). Since NTG
(untreated IOP < 21 mm Hg) is found more commonly in non-
Africans and has been associated previously with a thinner
CCT, we performed a sensitivity analysis by removing all NTG
patients (n ¼ 28) from our analyses. Excluding the NTG
patients from the main analysis did not change the association
between CCT and POAG (P ¼ 0.02; OR, 1.07; 95% CI, 1.01–
1.13); similarly, the multiplicative interaction between GAA
and CCT (P ¼ 0.102) did not change.
DISCUSSION
In this study, we found a statistically significant association
between GAA, CCT, and IOP in the South African study
population. Participants with a higher proportion of GAA had a
thinner CCT. African ancestry also was associated with higher
IOP in POAG patients. In the total study population, the POAG
patients had a significantly thinner CCT, but the association of
POAG and CCT was not statistically modified by differences in
GAA. However, when stratified by median GAA, only an
association between CCT and POAG for individuals with <60%
GAA remained statistically significant. This suggests that
genetic ancestry may have a role in the association between
POAG and CCT.
To our knowledge, this study is the first to investigate the
variation in CCT across different ethnic/racial groups in an
African population and its association with GAA. Only recently
have studies started to investigate the CCT in populations from
Sub-Saharan Africa, of which most are from West Africa (i.e.,
Ghana and Nigeria).35–38 In comparison with other African
studies, the mean CCT found for control participants in this
TABLE 2. Association of GAA, CCT, IOP, and POAG as Graphically Depicted in the Directed Acyclic Graph (Fig. 1)
Univariable Regression Model Multivariable Regression Model*
b 95% CI P Value b 95% CI P Value
1. CCT ~ GAA
All, n ¼ 381 3.58 4.65 to 2.51 <0.001 4.42 5.38 to 3.14 <0.001
Control, n ¼ 130 5.23 7.10 to 3.36 <0.001 5.41 7.36 to 3.45 <0.001
POAG, n ¼ 251 2.80 4.09 to 1.51 <0.001 3.68 5.06 to 2.30 <0.001
2. IOP ~ GAA
Control, n ¼ 129 0.14 0.29 to 0.01 0.069 0.12 0.28 to 0.04 0.131
POAG, n ¼ 200 0.63 0.24 to 1.02 0.002 0.46 0.05 to 0.87 0.029
3. IOP ~ CCT 0.204
Control, n ¼ 136 0.09 0.04 to 0.21 0.174 0.08 0.04 to 0.20
POAG, n ¼ 214 0.00 0.35 to 0.36 0.991 0.05 0.40 to 0.30 0.767
4. POAG ~ CCT, n ¼ 405 1.067† 1.01 to 1.13 0.020 1.07† 1.01 to 1.13 0.019
b¼ effect per 10% increase in GAA or 10 lm decrease in CCT.
* Multivariable regression model adjusted for age and sex.
† Odds ratio. Corresponds to the effect of 10 lm decrease in CCT.
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South African population was considerably thinner; it was even
the thinnest in any African study performed by means of
ultrasound pachymetry to date (i.e., 512 6 39.8; Fig. 4).28,35–46
Associations between GAA and CCT have been studied
previously in African Americans and Europeans in the ADAGES
study.47 This study found a similar correlation for CCT and GAA
in the entire group. However, a significant association between
GAA and CCT in the African American subgroup could not be
detected due to a limited degree of admixture in this group.
The association between IOP and GAA has been studied in
Latinos in the LALES study.48 This population-based study
found that IOP increases by 0.38 mm Hg for every 10% increase
in GAA. Although West Coast Latinos have a modest
contribution of GAA, our study found similar results, that is,
a 0.46 mm Hg increase per 10% increase in GAA, for POAG
patients. For controls, we did not find any association between
GAA and IOP. This could be explained by selection bias that
was induced by selecting only controls with an IOP < 21 mm
Hg. We did not observe a significant linear correlation between
IOP and CCT in either POAG patients or controls. Although
most population-based studies find a correlation between IOP
and CCT, case control studies could not always detect this
association in POAG patients due to selection of severe cases
with critical elevated IOP.
Most of the studies investigating the relationship between
glaucoma and CCT were based predominantly on European
ancestral populations and focused on ocular hypertension and
NTG patients. There have been conflicting reports about the
CCT of POAG patients versus controls. Several studies did not
find any statistically significant differences in CCT between
these groups.27,49–54 Yet, various other studies have, indeed,
reported such differences.26,55,56 A few studies have investi-
gated this relationship in African populations.26,35,37,44,46 Only
one of these detected a statistically significantly thinner CCT in
POAG patients, but this difference was only present in the left
eye.35 Also, the Barbados eye study found a thinner CCT in
POAG patients, but this difference was not statistically
significant (P ¼ 0.07).44 Recently, the Tema eye survey, the
largest population-based study of CCT on the African conti-
nent, could not find an association between CCT and POAG as
well.38
A novel finding of our study was that the difference in CCT
between POAG patients and controls attenuated by increasing
GAA (Fig. 3). This highlights that in individuals with a high
percentage of African ancestry, differences in CCT are little, if
at all, associated with POAG. This stresses the importance of
anatomic variation between ethnic/racial groups and the
TABLE 3. Association of CCT With POAG Stratified by Median
Proportion GAA
Strata
nPOAG;
ncontrol OR 95% CI
P
Value*
< median GAA (<59.6%) 122; 69 1.09 1.00–1.18 0.044
‡ median GAA (‡59.6%) 129; 61 1.04 0.94–1.14 0.477
OR, odds ratio per 10 lm decrease in CCT.
* Multivariable regression model adjusted for age and sex.
FIGURE 3. Scatter plot depicting the relation between GAA and CCT. Black dots represent POAG patients, every gray diamonds represent
controla. The black line is the linear regression adjusted for sex and age for POAG patients (CCTPOAG¼563.2–0.37*GAA). The gray line is the linear
regression adjusted for sex and age for controls (CCTcontrols ¼ 584.0–0.54*GAA).
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possible susceptibility for development of POAG. Investigation
into the racial and ethnic differences in the anatomy of the
optic nerve head showed, for instance, a thicker retinal nerve
fiber layer, and larger optic discs with deeper cups in African
individuals.57–61 In particular, a correlation between thinner
CCT and larger optic discs seems to be present in POAG
patients.62,63 Larger optic disc diameters may be associated
with increased vulnerability to pressure-induced deformation.
Therefore, eyes with thinner corneas are more susceptible to
glaucomatous damage in comparison with those having thicker
corneas. This hypothesis may explain why African persons are
more vulnerable to glaucomatous optic nerve head damage.
Although conflicting evidence exists that CCT is associated
with other disc topographic parameters (i.e., rim area, cup area
and VCDR).64–66 A new property of the cornea, corneal
hysteresis, has shown to be a better predictor of glaucomatous
damage.15,21
Our study has strengths and weaknesses. A strength of our
study is that by applying BGA estimation, we were able to
objectively measure variation in CCT and IOP related to ethnic/
racial differences. Self-reported ethnicity/race frequently is
used in epidemiologic studies to assess an individual’s
background origin. Often participants are asked to specify a
single ethnic/racial group based on categories. This method
can be unreliable, since these definitions can be imprecise and
inconsistent over time.67,68 Also, self-reported ethnicity/race
can be based on subjective physical characteristics and
intrinsic beliefs. Skin color, for example, often is used as
surrogate of race, although visual classification of skin color
can be interpreted differently.69–71 Especially in complex
admixed populations, such as SAC, self-reported ethnicity does
not reveal the extent of admixture, which is because admixed
individuals can have multiple ancestries, and these ancestry
proportions can vary greatly per individual. Recent advances in
genome-wide genotyping that allow the inference of BGA can
set aside the use of proxy methods, such as self-reported
ethnicity/race.71
The high degree of admixture in our study population also
is a valuable asset of the study, since it enabled detailed
evaluation of the differences in CCT and IOP in relation to
African ancestry.
A limitation of this study is its relatively small sample size.
As a result, this study had limited statistical power to find
significant interaction between GAA and CCT when studying
the association between CCT and POAG. Also, we performed
several numbers of tests. Therefore, chance finding should be
considered when interpreting the data. Post hoc power
analysis showed that this study was sufficiently powered
(power > 80%; P < 0.013; considering four tests), for the
multivariable associations in the POAG patients. We currently
are extending our genotyping efforts in a Tanzanian popula-
tion. As genotyping progresses, we will have more statistical
power to detect any significant differences. Preliminary data
from Tanzania strengthens our current findings and confirm
that in this African black population CCT is not different
among POAG patients and controls. Another limitation of this
study includes potential selection bias. For selecting POAG
patients based on functional damage (ISGEO category 1), we
applied rather strict criteria for assessing the reliability of the
visual fields. This might have led to a selection of super-test
takers, and, therefore, an undercalling of POAG patients. It
turned out, however, that 96% of the probable glaucoma cases
FIGURE 4. CCT in African POAG patients and non-glaucomatous African individuals. Error bars: Standard deviation. *Significant difference between
POAG patients and controls; Sng et al., no standard deviation available.
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that failed our strict reliability criteria were later identified as
glaucomatous, based on advanced structural optic nerve head
damage (ISGEO category 2). Therefore, the effects of our strict
visual field reliability criteria on our results probably were
insignificant. In controls, the IOP cutoff for enrolment could
have biased the associations in this group. Although high IOP is
the main risk factor for POAG, we might have overlooked
potentially healthy participants with elevated IOP.
In conclusion, this study shows that in African admixed
individuals GAA measurement is an unprejudiced tool to
distinguish associations with POAG and their endophenotypes.
We found that a higher proportion of GAA is associated with a
thinner CCT, and that an increase in GAA in POAG patients is
associated with a higher IOP. Interestingly, our current study
shows that the difference in CCT between POAG patients and
controls is reduced at higher proportions of GAA. This
confirms previous studies that did not find significant
differences in CCT between POAG patients and controls in
Africans.26,37,38,44,46 Therefore, some biomechanical properties
of the African eye may be different compared to those in other
ethnic groups. However, it is not yet clear to what extent they
relate to the increased glaucoma susceptibility of Africans.
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